bmp 7 (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
95
Structured Review
R&D Systems
bmp 7
Bmp 7, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 116 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+bmp+7/Recombinant+Human+BMP-7+Protein/pm41967630-70-6-14
Average 95 stars, based on 116 article reviews
Bmp 7, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 116 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+bmp+7/Recombinant+Human+BMP-7+Protein/pm41967630-70-6-14
Average 95 stars, based on 116 article reviews
bmp 7 - by Bioz Stars,
2026-10
95/100 stars
Images
Related Articles
Recombinant:Article Title: Intra-articular delivery of synovium-resident mesenchymal stem cells via BMP-7-loaded fibrous PLGA scaffolds for cartilage repair. Article Snippet: Accepted Manuscript Intra-articular delivery of synovium-resident mesenchymal stem cells via BMP-7-loaded fibrous PLGA scaffolds for cartilage repair Hee Jung Kim, Min Ah.. Han, Ji Young Shin, Jeong Hwa Jeon, Seung Jin Lee, Mi Yun Yoon, Han-Jun Kim, Eun-Ji Choi, Sun Hee Do, Victor C. Yang, Huining He, Young-Il Yang PII: S0168-3659(19)30194-4 DOI: https://doi.org/10.1016/j.jconrel.2019.04.002 Reference: COREL 9717 To appear in: Journal of Controlled Release Received date: 28 September 2018 Revised date: 31 March 2019 Accepted date: 3 April 2019 Please cite this article as: H.J.. Kim, M.A. Article Title: Dual Network Hydrogels Incorporated with Bone Morphogenic Protein-7-Loaded Hyaluronic Acid Complex Nanoparticles for Inducing Chondrogenic Differentiation of Synovium-Derived Mesenchymal Stem Cells Article Snippet: Hyaluronic acid (HA, sodium salt, M w : 90–110 kDa), and p -dioxanone were purchased from Sigma-Aldrich (Shanghai, China). .. Article Title: BMP7-induced-Pten inhibits Akt and prevents renal fibrosis. Article Snippet: .. 49 Animals were randomized into two groups (n=5 each) receiving vehicle (20mM histidine, 140mM NaCl, Roche) or 300g/kg Article Title: A combinatorial approach towards achieving an injectable, self-contained, phosphate-releasing scaffold for promoting biomineralization in critical size bone defects. Article Snippet: An injectable, guanosine 50-diphosphate (GDP)-crosslinked chitosan sponge was investigated as a drug delivery system (DDS) for accelerating biomineralization in critical size bone defects (CSBDs).. Two approaches were examined both individually, and in combination, in order to achieve this goal.. The first approach involved the encapsulation and release of Bone Morphogenetic Protein 7 (BMP-7), a powerful mineralization stimulant. Article Title: Radiolabeling and In Vivo Imaging of Transplanted Renal Lineages Differentiated from Human Embryonic Stem Cells in Fetal Rhesus Monkeys Article Snippet: .. Once cells were shown with a normal karyotype and documented to express luciferase, hES cell colonies were removed from underlying feeder layers by collagenase treatment and cultured in high-glucose DMEM medium containing 10% fetal bovine serum (Hyclone, Logan, UT), 1% Penicillin–Streptomycin, 1% L-glutamine, 100 μM 1-thioglycerol (Sigma) supplemented with 0.1 μM trans-Retinoic Acid (EMD Biosciences, San Diego, CA), 10 ng/ml Activin-A (R&D Systems, Minneapolis, MN), and 50 ng/ml Article Title: Effect of low-intensity pulsed ultrasound on bone morphogenetic protein 7-induced osteogenic differentiation of human nonunion tissue-derived cells in vitro. Article Snippet: lthough fracture healing is uneventful in most cases, 5% to 10% of fractures fail to heal and result in a delayed union or persistent nonunion.1,2 Autogenous bone grafting has been the standard technique for enhancing nonunion healing for many years.3 However, bone grafting has drawbacks, such as the need for an additional surgical site with its associated perioperative morbidity (eg, pain, potential infection, blood loss, and fracture),4 and limits exist with respect to the size, shape, and quantity of bone grafts available.. Other treatment techniques have thus been developed.. Biological Takaaki Koga, MD, Sang Yang Lee, MD, PhD, Takahiro Niikura, MD, PhD, Akihiro Koh, MD, PhD, Yoshihiro Dogaki, MD, Etsuko Okumachi, MD, Toshihiro Akisue, MD, PhD, Ryosuke Kuroda, MD, PhD, Masahiro Kurosaka, MD, PhD Article Title: Organotypic Rat Testicular Organoids for the Study of Testicular Maturation and Toxicology Article Snippet: .. ODM was composed of Minimum Essential Medium α (ThermoFisher Scientific, cat# 12571063) supplemented with 10% KnockOut Serum Replacement (ThermoFisher Scientific, cat# 10828028), hepatocyte growth factor (5 ng/mL) (R&D Systems, cat# 294-HG), activin A (100 ng/mL) (Sigma-Aldrich, cat# a4941), follicle stimulating hormone (1 ng/mL) (Sigma-Aldrich, cat# F4021), luteinizing hormone (1 ng/mL) (Sigma-Aldrich, cat# L5259), testosterone (1 μM) (Steraloids, cat# A6950-000), recombinant human BMP-4 (20 ng/mL) (R&D Systems, cat# 314-BP), Enzyme-linked Immunosorbent Assay:Article Title: Intra-articular delivery of synovium-resident mesenchymal stem cells via BMP-7-loaded fibrous PLGA scaffolds for cartilage repair. Article Snippet: Accepted Manuscript Intra-articular delivery of synovium-resident mesenchymal stem cells via BMP-7-loaded fibrous PLGA scaffolds for cartilage repair Hee Jung Kim, Min Ah.. Han, Ji Young Shin, Jeong Hwa Jeon, Seung Jin Lee, Mi Yun Yoon, Han-Jun Kim, Eun-Ji Choi, Sun Hee Do, Victor C. Yang, Huining He, Young-Il Yang PII: S0168-3659(19)30194-4 DOI: https://doi.org/10.1016/j.jconrel.2019.04.002 Reference: COREL 9717 To appear in: Journal of Controlled Release Received date: 28 September 2018 Revised date: 31 March 2019 Accepted date: 3 April 2019 Please cite this article as: H.J.. Kim, M.A. Article Title: Dual Network Hydrogels Incorporated with Bone Morphogenic Protein-7-Loaded Hyaluronic Acid Complex Nanoparticles for Inducing Chondrogenic Differentiation of Synovium-Derived Mesenchymal Stem Cells Article Snippet: Hyaluronic acid (HA, sodium salt, M w : 90–110 kDa), and p -dioxanone were purchased from Sigma-Aldrich (Shanghai, China). .. Article Title: A combinatorial approach towards achieving an injectable, self-contained, phosphate-releasing scaffold for promoting biomineralization in critical size bone defects. Article Snippet: An injectable, guanosine 50-diphosphate (GDP)-crosslinked chitosan sponge was investigated as a drug delivery system (DDS) for accelerating biomineralization in critical size bone defects (CSBDs).. Two approaches were examined both individually, and in combination, in order to achieve this goal.. The first approach involved the encapsulation and release of Bone Morphogenetic Protein 7 (BMP-7), a powerful mineralization stimulant. High Molecular Weight:Article Title: A combinatorial approach towards achieving an injectable, self-contained, phosphate-releasing scaffold for promoting biomineralization in critical size bone defects. Article Snippet: An injectable, guanosine 50-diphosphate (GDP)-crosslinked chitosan sponge was investigated as a drug delivery system (DDS) for accelerating biomineralization in critical size bone defects (CSBDs).. Two approaches were examined both individually, and in combination, in order to achieve this goal.. The first approach involved the encapsulation and release of Bone Morphogenetic Protein 7 (BMP-7), a powerful mineralization stimulant. Viscosity:Article Title: A combinatorial approach towards achieving an injectable, self-contained, phosphate-releasing scaffold for promoting biomineralization in critical size bone defects. Article Snippet: An injectable, guanosine 50-diphosphate (GDP)-crosslinked chitosan sponge was investigated as a drug delivery system (DDS) for accelerating biomineralization in critical size bone defects (CSBDs).. Two approaches were examined both individually, and in combination, in order to achieve this goal.. The first approach involved the encapsulation and release of Bone Morphogenetic Protein 7 (BMP-7), a powerful mineralization stimulant. Picogreen Assay:Article Title: A combinatorial approach towards achieving an injectable, self-contained, phosphate-releasing scaffold for promoting biomineralization in critical size bone defects. Article Snippet: An injectable, guanosine 50-diphosphate (GDP)-crosslinked chitosan sponge was investigated as a drug delivery system (DDS) for accelerating biomineralization in critical size bone defects (CSBDs).. Two approaches were examined both individually, and in combination, in order to achieve this goal.. The first approach involved the encapsulation and release of Bone Morphogenetic Protein 7 (BMP-7), a powerful mineralization stimulant. Pyrophosphate Assay:Article Title: A combinatorial approach towards achieving an injectable, self-contained, phosphate-releasing scaffold for promoting biomineralization in critical size bone defects. Article Snippet: An injectable, guanosine 50-diphosphate (GDP)-crosslinked chitosan sponge was investigated as a drug delivery system (DDS) for accelerating biomineralization in critical size bone defects (CSBDs).. Two approaches were examined both individually, and in combination, in order to achieve this goal.. The first approach involved the encapsulation and release of Bone Morphogenetic Protein 7 (BMP-7), a powerful mineralization stimulant. Staining:Article Title: A combinatorial approach towards achieving an injectable, self-contained, phosphate-releasing scaffold for promoting biomineralization in critical size bone defects. Article Snippet: An injectable, guanosine 50-diphosphate (GDP)-crosslinked chitosan sponge was investigated as a drug delivery system (DDS) for accelerating biomineralization in critical size bone defects (CSBDs).. Two approaches were examined both individually, and in combination, in order to achieve this goal.. The first approach involved the encapsulation and release of Bone Morphogenetic Protein 7 (BMP-7), a powerful mineralization stimulant. Cell Culture:Article Title: A combinatorial approach towards achieving an injectable, self-contained, phosphate-releasing scaffold for promoting biomineralization in critical size bone defects. Article Snippet: An injectable, guanosine 50-diphosphate (GDP)-crosslinked chitosan sponge was investigated as a drug delivery system (DDS) for accelerating biomineralization in critical size bone defects (CSBDs).. Two approaches were examined both individually, and in combination, in order to achieve this goal.. The first approach involved the encapsulation and release of Bone Morphogenetic Protein 7 (BMP-7), a powerful mineralization stimulant. Article Title: Radiolabeling and In Vivo Imaging of Transplanted Renal Lineages Differentiated from Human Embryonic Stem Cells in Fetal Rhesus Monkeys Article Snippet: .. Once cells were shown with a normal karyotype and documented to express luciferase, hES cell colonies were removed from underlying feeder layers by collagenase treatment and cultured in high-glucose DMEM medium containing 10% fetal bovine serum (Hyclone, Logan, UT), 1% Penicillin–Streptomycin, 1% L-glutamine, 100 μM 1-thioglycerol (Sigma) supplemented with 0.1 μM trans-Retinoic Acid (EMD Biosciences, San Diego, CA), 10 ng/ml Activin-A (R&D Systems, Minneapolis, MN), and 50 ng/ml Article Title: Effect of low-intensity pulsed ultrasound on bone morphogenetic protein 7-induced osteogenic differentiation of human nonunion tissue-derived cells in vitro. Article Snippet: lthough fracture healing is uneventful in most cases, 5% to 10% of fractures fail to heal and result in a delayed union or persistent nonunion.1,2 Autogenous bone grafting has been the standard technique for enhancing nonunion healing for many years.3 However, bone grafting has drawbacks, such as the need for an additional surgical site with its associated perioperative morbidity (eg, pain, potential infection, blood loss, and fracture),4 and limits exist with respect to the size, shape, and quantity of bone grafts available.. Other treatment techniques have thus been developed.. Biological Takaaki Koga, MD, Sang Yang Lee, MD, PhD, Takahiro Niikura, MD, PhD, Akihiro Koh, MD, PhD, Yoshihiro Dogaki, MD, Etsuko Okumachi, MD, Toshihiro Akisue, MD, PhD, Ryosuke Kuroda, MD, PhD, Masahiro Kurosaka, MD, PhD Pore Size:Article Title: A combinatorial approach towards achieving an injectable, self-contained, phosphate-releasing scaffold for promoting biomineralization in critical size bone defects. Article Snippet: An injectable, guanosine 50-diphosphate (GDP)-crosslinked chitosan sponge was investigated as a drug delivery system (DDS) for accelerating biomineralization in critical size bone defects (CSBDs).. Two approaches were examined both individually, and in combination, in order to achieve this goal.. The first approach involved the encapsulation and release of Bone Morphogenetic Protein 7 (BMP-7), a powerful mineralization stimulant. Positron Emission Tomography:Article Title: A combinatorial approach towards achieving an injectable, self-contained, phosphate-releasing scaffold for promoting biomineralization in critical size bone defects. Article Snippet: An injectable, guanosine 50-diphosphate (GDP)-crosslinked chitosan sponge was investigated as a drug delivery system (DDS) for accelerating biomineralization in critical size bone defects (CSBDs).. Two approaches were examined both individually, and in combination, in order to achieve this goal.. The first approach involved the encapsulation and release of Bone Morphogenetic Protein 7 (BMP-7), a powerful mineralization stimulant. ALP Assay:Article Title: A combinatorial approach towards achieving an injectable, self-contained, phosphate-releasing scaffold for promoting biomineralization in critical size bone defects. Article Snippet: An injectable, guanosine 50-diphosphate (GDP)-crosslinked chitosan sponge was investigated as a drug delivery system (DDS) for accelerating biomineralization in critical size bone defects (CSBDs).. Two approaches were examined both individually, and in combination, in order to achieve this goal.. The first approach involved the encapsulation and release of Bone Morphogenetic Protein 7 (BMP-7), a powerful mineralization stimulant. Luciferase:Article Title: Radiolabeling and In Vivo Imaging of Transplanted Renal Lineages Differentiated from Human Embryonic Stem Cells in Fetal Rhesus Monkeys Article Snippet: .. Once cells were shown with a normal karyotype and documented to express luciferase, hES cell colonies were removed from underlying feeder layers by collagenase treatment and cultured in high-glucose DMEM medium containing 10% fetal bovine serum (Hyclone, Logan, UT), 1% Penicillin–Streptomycin, 1% L-glutamine, 100 μM 1-thioglycerol (Sigma) supplemented with 0.1 μM trans-Retinoic Acid (EMD Biosciences, San Diego, CA), 10 ng/ml Activin-A (R&D Systems, Minneapolis, MN), and 50 ng/ml Derivative Assay:Article Title: Effect of low-intensity pulsed ultrasound on bone morphogenetic protein 7-induced osteogenic differentiation of human nonunion tissue-derived cells in vitro. Article Snippet: lthough fracture healing is uneventful in most cases, 5% to 10% of fractures fail to heal and result in a delayed union or persistent nonunion.1,2 Autogenous bone grafting has been the standard technique for enhancing nonunion healing for many years.3 However, bone grafting has drawbacks, such as the need for an additional surgical site with its associated perioperative morbidity (eg, pain, potential infection, blood loss, and fracture),4 and limits exist with respect to the size, shape, and quantity of bone grafts available.. Other treatment techniques have thus been developed.. Biological Takaaki Koga, MD, Sang Yang Lee, MD, PhD, Takahiro Niikura, MD, PhD, Akihiro Koh, MD, PhD, Yoshihiro Dogaki, MD, Etsuko Okumachi, MD, Toshihiro Akisue, MD, PhD, Ryosuke Kuroda, MD, PhD, Masahiro Kurosaka, MD, PhD Knock-Out:Article Title: Organotypic Rat Testicular Organoids for the Study of Testicular Maturation and Toxicology Article Snippet: .. ODM was composed of Minimum Essential Medium α (ThermoFisher Scientific, cat# 12571063) supplemented with 10% KnockOut Serum Replacement (ThermoFisher Scientific, cat# 10828028), hepatocyte growth factor (5 ng/mL) (R&D Systems, cat# 294-HG), activin A (100 ng/mL) (Sigma-Aldrich, cat# a4941), follicle stimulating hormone (1 ng/mL) (Sigma-Aldrich, cat# F4021), luteinizing hormone (1 ng/mL) (Sigma-Aldrich, cat# L5259), testosterone (1 μM) (Steraloids, cat# A6950-000), recombinant human BMP-4 (20 ng/mL) (R&D Systems, cat# 314-BP), |
![Knockdown of BMP7 ameliorates hypoxia-induced pulmonary hypertension in vivo. A-B RVSP measurements and representative traces from mice in the indicated groups ( n = 6). C Quantification of right ventricular hypertrophy, presented as the ratio of right ventricular weight to the sum of left ventricular and septal weights [RV/(LV + S)] ( n = 6). D-F Echocardiographic analyses of PAVTI and the PAT/PET ratio were performed on the different groups ( n = 6). G-H Representative H&E-stained lung sections and quantitative analysis of vascular wall thickness ( n = 6). Scale bar: 100 μm. I-J Western blot analysis and quantification of PCNA protein expression in lung tissues ( n = 6). K-L Western blot quantification of cyclin A2/B2/D1 in lung tissues from different experimental groups ( n = 6). Data are depicted as scatter plots with the median and interquartile range superimposed. Significance: * P < 0.05, ** P < 0.01, *** P < 0.001](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_0850/pmc12910850/pmc12910850__12931_2025_3436_Fig6_HTML.jpg)
